CTSB and early-onset autosomal dominant Alzheimer disease: CTSB levels are elevated in the CSF as well as brain parenchyma of patients with Alzheimer’s disease [67–70], and knockout of Ctsb has been shown to ameliorate the neuropathology and behavioral deficits in mouse models of Alzheimer’s disease [71–73].